Insight Molecular Diagnostics

IMDX

Börsenwert 83,4 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	17 Mio. $	–	–	–
2	2 Pura Vida Investments New York	13,2 Mio. $	–	–	–
3	AIC 3 AWM Investment Company New York	5,66 Mio. $	–	–	–
4	4 Vanguard Group Malvern, Pennsylvania	3,18 Mio. $	+8.795 $	+508	+0,2 %
5	5 Defender Capital Charlotte, North Carolina	1,88 Mio. $	-32.376 $	-1.870	-1 %
6	6 BlackRock New York	1,68 Mio. $	-32.965 $	-1.904	-2 %
7	7 OrbiMed New York	1,37 Mio. $	-826.749 $	-47.752	-34 %
8	8 Geode Capital Management Boston, Massachusetts	726.000 $	+18.733 $	+1.082	+2 %
9	9 Schonfeld Strategic Advisors New York	547.000 $	-179.800 $	-10.385	-22 %
10	10 Millennium Management New York	527.000 $	-237.869 $	-13.739	-28 %
11	11 Penbrook Management New York	411.000 $	-10.734 $	-620	-2 %
12	12 Goldman Sachs New York	279.000 $	-138.888 $	-8.022	-30 %
13	13 ACT Capital Management Wayne, Pennsylvania	241.000 $	–	–	–
14	14 State Street Boston, Massachusetts	206.000 $	-39.215 $	-2.265	-14 %
15	15 Northern Trust Chicago, Illinois	152.000 $	–	–	–
16	16 Bridgeway Capital Management Houston, Texas	150.000 $	–	–	–
17	17 IFP Advisors Tampa, Florida	106.000 $	–	–	–
18	18 LPL Financial San Diego, California	101.000 $	+25.987 $	+1.501	+28 %
19	19 Fort Sheridan Advisors Highland Park, Illinois	99.000 $	–	–	–
20	20 Morgan Stanley New York	80.000 $	-33.848 $	-1.955	-26 %
21	21 Caliber Wealth Management (Utah) Orem, Utah	55.000 $	–	–	–
22	22 Deutsche Bank Frankfurt Am Main Ge, Germany	49.000 $	–	–	–
23	E 23 Ergoteles New York	47.000 $	-145.294 $	-8.392	-72 %
24	24 Bank of America Charlotte, North Carolina	46.000 $	-47.318 $	-2.733	-46 %
25	25 Bank of New York Mellon New York	46.000 $	–	–	–

Insight Molecular Diagnostics IMDX Börsenwert 83,4 Mio. $

Insight Molecular Diagnostics

IMDX

Börsenwert 83,4 Mio. $